Deng Wei, Wang Tianshu, Li Lei, Xiao Xuanyu, Xu Yuanyuan, Li Qiujiang, Zhou Qingsong, Yin Yong, Yang Hongsheng, Gong Kai, Zhou Yue, Wang Yunbing
Department of Orthopedics, The Third Affiliated Hospital of Chengdu Medical College, Chengdu Pidu District People's Hospital, Chengdu, Sichuan 611730, China.
National Engineering Research Center for Biomaterials & College of Biomedical Engineering, Sichuan University, Chengdu, Sichuan 610065, China.
Regen Biomater. 2025 Jun 4;12:rbaf048. doi: 10.1093/rb/rbaf048. eCollection 2025.
Osteoarthritis (OA) is a highly prevalent degenerative cartilage disease globally. The medical community has recognized it as one of the major public health problems today. Nanomaterials are considered the most promising avenue for OA treatment because they exhibit unique physicochemical properties such as high catalytic activity, bio-enzyme-like reaction kinetics, and modulation of joint immune responses. Besides, nanomaterials can exert higher targeting to improve therapeutic efficacy and reduce side effects. These unique advantages have led to the widespread development of nanomaterials for OA treatment, and they are gradually seeing their most prosperous moment. A timely and comprehensive review of OA pathogenesis-immunomodulation-therapeutic efficacy from a nanomaterials perspective would greatly broaden this research area. This review summarizes the recent advances in nanomaterials for OA treatment. Finally, the main challenges and opportunities for nanomaterials to modulate the immune system for OA treatment are discussed.
骨关节炎(OA)是一种在全球范围内高度流行的退行性软骨疾病。医学界已将其视为当今主要的公共卫生问题之一。纳米材料因其具有诸如高催化活性、类生物酶反应动力学以及调节关节免疫反应等独特的物理化学性质,而被认为是治疗骨关节炎最具前景的途径。此外,纳米材料能够实现更高的靶向性,以提高治疗效果并减少副作用。这些独特优势促使纳米材料在骨关节炎治疗领域得到广泛发展,并且它们正逐渐迎来最为繁荣的时期。从纳米材料角度对骨关节炎发病机制 - 免疫调节 - 治疗效果进行及时且全面的综述,将极大地拓宽这一研究领域。本综述总结了纳米材料在骨关节炎治疗方面的最新进展。最后,讨论了纳米材料在调节免疫系统以治疗骨关节炎方面面临的主要挑战和机遇。